tiprankstipranks
IXICO PLC (GB:IXI)
LSE:IXI
Holding GB:IXI?
Track your performance easily

IXICO plc (IXI) Share Price & Analysis

10 Followers

IXI Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

1.41%98.59%
― Other Institutional Investors
98.59% Public Companies and
Individual Investors

IXI FAQ

What was IXICO PLC’s price range in the past 12 months?
IXICO PLC lowest share price was 6.35p and its highest was 14.60p in the past 12 months.
    What is IXICO PLC’s market cap?
    Currently, no data Available
    When is IXICO PLC’s upcoming earnings report date?
    IXICO PLC’s upcoming earnings report date is May 27, 2025 which is in 153 days.
      How were IXICO PLC’s earnings last quarter?
      IXICO PLC released its earnings results on Dec 04, 2024. The company reported -0.012p earnings per share for the quarter, missing the consensus estimate of N/A by -0.012p.
        Is IXICO PLC overvalued?
        According to Wall Street analysts IXICO PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does IXICO PLC pay dividends?
          IXICO PLC does not currently pay dividends.
          What is IXICO PLC’s EPS estimate?
          IXICO PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does IXICO PLC have?
          IXICO PLC has 92,668,594 shares outstanding.
            What happened to IXICO PLC’s price movement after its last earnings report?
            IXICO PLC reported an EPS of -0.012p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.245%.
              Which hedge fund is a major shareholder of IXICO PLC?
              Currently, no hedge funds are holding shares in GB:IXI
              ---

              Company Description

              IXICO PLC

              IXICO PLC is a UK-based company. It is engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. The company's products include Assessa which is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes and health- secure online software for clinicians at the point-of-care to support patient-centred, evidence-based decision making and improve the monitoring and treatment of patients. Also, the company offers a web-based system to track imaging-based research study in real time. Most of the company's revenue comes from the United States.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Creo Medical
              N4 Pharma
              Feedback
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis